TrialInternational journal of colorectal disease2019

A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort.

Raunak Jay Soman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.